Spots Global Cancer Trial Database for tegafur
Every month we try and update this database with for tegafur cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PPIO-008S-1 Combined With Tislelizumab in Patients With Primary Residual Node-negative Esophageal Squamous Cell Carcinoma (ESCC) After Radical Resection With Neoadjuvant Immunotherapy Combined With Chemotherapy, PHASE II STUDY | NCT06354140 | Postoperative A... | Tegafur | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor | NCT03204019 | Pancreatic Neur... | Tegafur and Tem... Tegafur and Tem... | 18 Years - | ChineseAMS | |
| HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer | NCT06383078 | Efficacy and Sa... | HR070803 Oxaliplatin Tegafur Folinic acid 5-Fluorouracil | 20 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer | NCT01972503 | Colorectal Neop... Neoplasm Metast... Liver Neoplasms | 5-FU and oxalip... colorectal canc... | 18 Years - 75 Years | Fudan University | |
| Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC | NCT03175705 | Hepatocellular ... | HCC antigens-sp... IL-2 Tegafur | 18 Years - 80 Years | Beijing YouAn Hospital | |
| Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma | NCT06339619 | Locally Advance... | Adebrelimab Apatinib Tegafur | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer | NCT00524706 | Colorectal Canc... | S-1, oral Leuco... | 20 Years - 74 Years | Shizuoka Cancer Center | |
| Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer | NCT03406299 | Biliary Tract N... | Tegafur Leucovorin Oxaliplatin Gemcitabine Cisplatin | 20 Years - | National Health Research Institutes, Taiwan | |
| Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | NCT04135781 | Stomach Cancer | nab paclitaxel Tegafur Oxaliplatin Capecitabine | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma | NCT06339619 | Locally Advance... | Adebrelimab Apatinib Tegafur | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy | NCT05817201 | Esophageal Canc... Radiation Thera... Immunotherapy Chemotherapy | Toripalimab Tegafur IMRT | 70 Years - 85 Years | Taizhou Hospital | |
| Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer | NCT05914610 | Gastric Cancer | Envolimab Fruquintinib Oxaliplatin Tegafur | 18 Years - 75 Years | Fujian Medical University | |
| Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma | NCT03702491 | Gallbladder Car... | Apatinib Tegafur | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction | NCT06396585 | Immunotherapy G... | Tislelizumab Anlotinib Oxaliplatin Tegafur | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | NCT04135781 | Stomach Cancer | nab paclitaxel Tegafur Oxaliplatin Capecitabine | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC | NCT03175679 | Hepatocellular ... | iNKT cells IL-2 Tegafur | 18 Years - 80 Years | Beijing YouAn Hospital | |
| Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer | NCT05914610 | Gastric Cancer | Envolimab Fruquintinib Oxaliplatin Tegafur | 18 Years - 75 Years | Fujian Medical University | |
| Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer | NCT00524706 | Colorectal Canc... | S-1, oral Leuco... | 20 Years - 74 Years | Shizuoka Cancer Center | |
| PPIO-008S-1 Combined With Tislelizumab in Patients With Primary Residual Node-negative Esophageal Squamous Cell Carcinoma (ESCC) After Radical Resection With Neoadjuvant Immunotherapy Combined With Chemotherapy, PHASE II STUDY | NCT06354140 | Postoperative A... | Tegafur | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer | NCT04216758 | Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... | nab-paclitaxel Gemcitabine tegafur | 18 Years - 80 Years | Fudan University | |
| Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer | NCT05223088 | Immunotherapy Gastrict Cancer | Tislelizumab Apatinib Mesyla... oxaliplatin Tegafur | 18 Years - 75 Years | Fujian Cancer Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
